D. E. Shaw & Co., Inc.

SEC CIK: 0001009207
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

AKTS holding history

Aktis Oncology, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AKTS overview All 13F holders of AKTS Full Q2 2026 holdings

Shares (Q2 2026): 0; Sold out in Q2 2026
Value: $0
% of portfolio: 0.0%
Quarters held: 1; Since Q1 2026

Holdings of AKTS by D. E. Shaw & Co., Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	0	$0	0.0%	−17,062−100.0%	Sold out	Holders
Q1 2026	17,062	$305.2K	<0.1%	+17,062	New	Holders